1921
Volume 90, Issue 1
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

We report the first case of visceral leishmaniasis caused by in a seronegative child. She was treated with amphotericin B at 1 mg/kg/day for 3 weeks; however, recurrences occurred twice. The patient was cured after the administration of amphotericin B for 5 weeks and monthly prophylaxis for 6 months.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.13-0398
2014-01-08
2017-09-23
Loading full text...

Full text loading...

/deliver/fulltext/14761645/90/1/40.html?itemId=/content/journals/10.4269/ajtmh.13-0398&mimeType=html&fmt=ahah

References

  1. El Tai NO, El Fari M, Mauricio I, Miles MA, Oskam L, El Safi SH, Presber WH, Schönian G, , 2001. Leishmania donovani: intraspecific polymorphisms of Sudanese isolates revealed by PCR-based analyses and DNA sequencing. Exp Parasitol 97: 3544.[Crossref]
  2. Thakur CP, Singh RK, Hassan SM, Kumar R, Narain S, Kumar A, , 1999. Amphotericin B deoxycholate treatment of visceral leishmaniasis with newer modes of administration and precautions: a study of 938 cases. Trans R Soc Trop Med Hyg 93: 319323.[Crossref]
  3. Sukmee T, Siripattanapipong S, Mungthin M, Worapong J, Rangsin R, Samung Y, Kongkaew W, Bumrungsana K, Chanachai K, Apiwathanasorn C, Rujirojindakul P, Wattanasri S, Ungchusak K, Leelayoova S, , 2008. A suspected new species of Leishmania, the causative agent of visceral leishmaniasis in a Thai patient. Int J Parasitol 38: 617622.[Crossref]
  4. Bualert L, Charungkiattikul W, Thongsuksai P, Mungthin M, Siripattanapipong S, Khositnithikul R, Naaglor T, Ravel C, El Baidouri F, Leelayoova S, , 2012. Autochthonous disseminated dermal and visceral leishmaniasis in an AIDS patient, southern Thailand, caused by Leishmania siamensis . Am J Trop Med Hyg 86: 821824.[Crossref]
  5. Chusri S, Hortiwakul T, Silpapojakul K, Siriyasatien P, , 2012. Consecutive cutaneous and visceral leishmaniasis manifestations involving a novel Leishmania species in two HIV patients in Thailand. Am J Trop Med Hyg 87: 7680.[Crossref]
  6. Suankratay C, Suwanpimolkul G, Wilde H, Siriyasatien P, , 2010. Autochthonous visceral leishmaniasis in a human immunodeficiency virus (HIV)-infected patient: the first in Thailand and review of the literature. Am J Trop Med Hyg 82: 48.[Crossref]
  7. Lobsiger L, Muller N, Schweizer T, Frey CF, Wiederkehr D, Zumkehr B, Gottstein B, , 2010. An autochthonous case of cutaneous bovine leishmaniasis in Switzerland. Vet Parasitol 169: 408414.[Crossref]
  8. Müller N, Welle M, Lobsiger L, Stoffel MH, Boghenbor KK, Hilbe M, Gottstein B, Frey CF, Geyer C, von Bomhard W, , 2009. Occurrence of Leishmania sp. in cutaneous lesions of horses in Central Europe. Vet Parasitol 166: 346351.[Crossref]
  9. Reuss SM, Dunbar MD, Calderwood Mays MB, Owen JL, Mallicote MF, Archer LL, Wellehan JF, Jr, 2012. Autochthonous Leishmania siamensis in horse, Florida, USA. Emerg Infect Dis 18: 15451547.[Crossref]
  10. Paila YD, Saha B, Chattopadhyay A, , 2010. Amphotericin B inhibits entry of Leishmania donovani into primary macrophages. Biochem Biophys Res Commun 399: 429433.[Crossref]
  11. Sundar S, Rai M, , 2005. Treatment of visceral leishmaniasis. Expert Opin Pharmacother 6: 28212829.[Crossref]
  12. Rosenthal E, Marty P, Poizot-Martin I, Reynes J, Pratlong F, Lafeuillade A, Jaubert D, Boulat O, Dereure J, Gambarelli F, , 1995. Visceral leishmaniasis and HIV-1 co-infection in southern France. Trans R Soc Trop Med Hyg 89: 159162.[Crossref]
  13. Laguna F, , 2003. Treatment of leishmaniasis in HIV-positive patients. Ann Trop Med Parasitol 97 (Suppl 1): 135142.[Crossref]
  14. Lachaud L, Bourgeois N, Plourde M, Leprohon P, Bastien P, Ouellette M, , 2009. Parasite susceptibility to amphotericin B in failures of treatment for visceral leishmaniasis in patients coinfected with HIV type 1 and Leishmania infantum . Clin Infect Dis 48: e16e22.[Crossref]
  15. Leelayoova S, Siripattanapipong S, Hitakarun A, Kato H, Tan-ariya P, Siriyasatien P, Osatakul S, Mungthin M, , 2013. Multilocus characterization and phylogenetic analysis of Leishmania siamensis isolated from autochthonous visceral leishmaniasis cases, southern Thailand. BMC Microbiol 13: 60.[Crossref]
  16. Murray HW, Berman JD, Davies CR, Saravia NG, , 2005. Advances in leishmaniasis. Lancet 366: 15611577.[Crossref]
  17. Cota GF, de Sousa MR, Rabello A, , 2011. Predictors of visceral leishmaniasis relapse in HIV-infected patients: a systematic review. PLoS Negl Trop Dis 5: e1153.[Crossref]
  18. Molina I, Falcó V, Crespo M, Riera C, Ribera E, Curran A, Carrio J, Diaz M, Villar del Saz S, Fisa R, López-Chejade P, Ocaña I, Pahissa A, , 2007. Efficacy of liposomal amphotericin B for secondary prophylaxis of visceral leishmaniasis in HIV-infected patients. J Antimicrob Chemother 60: 837842.[Crossref]
  19. Berenguer J, Cosin J, Miralles P, Lopez JC, Padilla B, , 2000. Discontinuation of secondary anti-leishmania prophylaxis in HIV-infected patients who have responded to highly active antiretroviral therapy. AIDS 14: 29462948.[Crossref]
  20. López-Vélez R, Videla S, Márquez M, Boix V, Jiménez-Mejías ME, Górgolas M, Arribas JR, Salas A, Laguna F, Sust M, Cañavate C, Alvar J, Spanish HIV-Leishmania Study Group; , 2004. Amphotericin B lipid complex versus no treatment in the secondary prophylaxis of visceral leishmaniasis in HIV-infected patients. J Antimicrob Chemother 53: 540543.[Crossref]
  21. Laguna F, , 2003. Treatment of leishmaniasis in HIV-positive patients. Ann Trop Med Parasitol 97: 135142.[Crossref]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.13-0398
Loading
  • Received : 09 Jul 2013
  • Accepted : 19 Oct 2013

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error